228 related articles for article (PubMed ID: 28696894)
1. Preference of Aerosolized Pirfenidone to Oral Intake: An Experimental Model of Pulmonary Fibrosis by Paraquat.
Rasooli R; Rajaian H; Pardakhty A; Mandegary A
J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):25-32. PubMed ID: 28696894
[TBL] [Abstract][Full Text] [Related]
2. Combination Therapy with Pirfenidone plus Prednisolone Ameliorates Paraquat-Induced Pulmonary Fibrosis.
Rasooli R; Pourgholamhosein F; Kamali Y; Nabipour F; Mandegary A
Inflammation; 2018 Feb; 41(1):134-142. PubMed ID: 28921394
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone protects against paraquat-induced lung injury and fibrosis in mice by modulation of inflammation, oxidative stress, and gene expression.
Pourgholamhossein F; Rasooli R; Pournamdari M; Pourgholi L; Samareh-Fekri M; Ghazi-Khansari M; Iranpour M; Poursalehi HR; Heidari MR; Mandegary A
Food Chem Toxicol; 2018 Feb; 112():39-46. PubMed ID: 29273418
[TBL] [Abstract][Full Text] [Related]
4. Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.
Tian XL; Yao W; Guo ZJ; Gu L; Zhu YJ
Chin Med Sci J; 2006 Sep; 21(3):145-51. PubMed ID: 17086734
[TBL] [Abstract][Full Text] [Related]
5. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.
Tanaka KI; Azuma A; Miyazaki Y; Sato K; Mizushima T
Chest; 2012 Oct; 142(4):1011-1019. PubMed ID: 22459774
[TBL] [Abstract][Full Text] [Related]
6. A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis.
Khoo JK; Montgomery AB; Otto KL; Surber M; Faggian J; Lickliter JD; Glaspole I
J Aerosol Med Pulm Drug Deliv; 2020 Feb; 33(1):15-20. PubMed ID: 30698487
[No Abstract] [Full Text] [Related]
7. [The study of effects of pirfenidone on the pulmonary fibrosis induced by paraquat in mice].
Li JW; Shen XW; Sun W; Xiao M; Tong SH; Yu XC; Lu ZQ; Hu GX
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Feb; 29(2):87-93. PubMed ID: 21619834
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of Berberis vulgaris fruit extract against Paraquat-induced pulmonary fibrosis in rats.
Javad-Mousavi SA; Hemmati AA; Mehrzadi S; Hosseinzadeh A; Houshmand G; Rashidi Nooshabadi MR; Mehrabani M; Goudarzi M
Biomed Pharmacother; 2016 Jul; 81():329-336. PubMed ID: 27261610
[TBL] [Abstract][Full Text] [Related]
9. Effect of pirfenidone on pulmonary fibrosis due to paraquat poisoning in rats.
Seifirad S; Keshavarz A; Taslimi S; Aran S; Abbasi H; Ghaffari A
Clin Toxicol (Phila); 2012 Sep; 50(8):754-8. PubMed ID: 22924653
[TBL] [Abstract][Full Text] [Related]
10. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
11. Antiadhesive and anti-inflammatory effects of pirfenidone in postoperative intra-abdominal adhesion in an experimental rat model.
Bayhan Z; Zeren S; Kocak FE; Kocak C; Akcılar R; Kargı E; Tiryaki C; Yaylak F; Akcılar A
J Surg Res; 2016 Apr; 201(2):348-55. PubMed ID: 27020818
[TBL] [Abstract][Full Text] [Related]
12. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone effectively alleviates lung fibrosis induced by paraquat herbicide through down-regulation of pro-fibrotic genes and inhibition of oxidative stress.
Pourgholamhossein F; Sharififar F; Rasooli R; Pourgholi L; Nakhaeipour F; Samareh-Fekri H; Iranpour M; Mandegary A
Environ Toxicol Pharmacol; 2016 Jul; 45():340-5. PubMed ID: 27375216
[TBL] [Abstract][Full Text] [Related]
14. Aerosol Pirfenidone Pharmacokinetics after Inhaled Delivery in Sheep: a Viable Approach to Treating Idiopathic Pulmonary Fibrosis.
Kaminskas LM; Landersdorfer CB; Bischof RJ; Leong N; Ibrahim J; Davies AN; Pham S; Beck S; Montgomery AB; Surber MW
Pharm Res; 2019 Dec; 37(1):3. PubMed ID: 31823096
[TBL] [Abstract][Full Text] [Related]
15. Losartan attenuates paraquat-induced pulmonary fibrosis in rats.
Guo F; Sun YB; Su L; Li S; Liu ZF; Li J; Hu XT; Li J
Hum Exp Toxicol; 2015 May; 34(5):497-505. PubMed ID: 25233898
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice.
Chen Y; Nie YC; Luo YL; Lin F; Zheng YF; Cheng GH; Wu H; Zhang KJ; Su WW; Shen JG; Li PB
Food Chem Toxicol; 2013 Aug; 58():133-40. PubMed ID: 23603004
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
[TBL] [Abstract][Full Text] [Related]
18. Effect of pirfenidone on gastric emptying in a rat model.
Pan L; Gelzleichter T; Chen Y; Burg C; Limb SL; Nguyen L
Pulm Pharmacol Ther; 2018 Aug; 51():41-47. PubMed ID: 29944949
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation.
Iyer SN; Hyde DM; Giri SN
Inflammation; 2000 Oct; 24(5):477-91. PubMed ID: 10921510
[TBL] [Abstract][Full Text] [Related]
20. Edaravone, a novel antidote against lung injury and pulmonary fibrosis induced by paraquat?
Zhi Q; Sun H; Qian X; Yang L
Int Immunopharmacol; 2011 Jan; 11(1):96-102. PubMed ID: 21040696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
